公开(公告)号：EP0442744A3

公开(公告)日：1992-07-15

申请号：EP91301212.6

申请日：1991-02-14

申请人： TSUMURA & CO. ,  Tanaka, Yasuo

发明人： Tanaka, Yasuo ,  Takechi,Masayuki

IPC分类号： A61K31/585 ,  A61K31/705

CPC分类号： A61K31/704 ,  A61K31/585 ,  A61K31/7048 ,  A61K2300/00

摘要： A use of a compound of the formula:

wherein
R₁, R₂, R₃ and R₄ are independently hydrogen atom or hydroxy group,
R₅ is hydrogen atom, methyl, hydroxymethyl, or formyl group,
R₆ is hydrogen atom or methyl group,
R₇ is 2,5-dihydro-2-oxofuran-4-yl group, or 2-oxo-2H-pyran-4-yl group, and
R₈ is hydrogen atom or sugar group,
with the proviso that, when R₇ is 2,5-dihydro-2-oxofuran-4-yl, then R₈ is not hydrogen atom,
or a 4,5-unsaturated compound corresponding thereto, as an active ingredient, for the manufacture of a medicament for the treatment of viral diseases.

公开(公告)号：EP0442744A2

公开(公告)日：1991-08-21

申请号：EP91301212.6

申请日：1991-02-14

申请人： TSUMURA & CO. ,  Tanaka, Yasuo

发明人： Tanaka, Yasuo ,  Takechi,Masayuki

IPC分类号： A61K31/585 ,  A61K31/705

CPC分类号： A61K31/704 ,  A61K31/585 ,  A61K31/7048 ,  A61K2300/00

摘要： A use of a compound of the formula:

wherein
R₁, R₂, R₃ and R₄ are independently hydrogen atom or hydroxy group,
R₅ is hydrogen atom, methyl, hydroxymethyl, or formyl group,
R₆ is hydrogen atom or methyl group,
R₇ is 2,5-dihydro-2-oxofuran-4-yl group, or 2-oxo-2H-pyran-4-yl group, and
R₈ is hydrogen atom or sugar group,
with the proviso that, when R₇ is 2,5-dihydro-2-oxofuran-4-yl, then R₈ is not hydrogen atom,
or a 4,5-unsaturated compound corresponding thereto, as an active ingredient, for the manufacture of a medicament for the treatment of viral diseases.

摘要翻译： 使用下式的化合物，其中R 1，R 2，R 3和R 4独立地是氢原子或羟基，R 5是氢原子，甲基，羟甲基或甲酰基，R 6是氢原子或甲基，R 7 是2,5-二氢-2-氧代呋喃-4-基或2-氧代-2H-吡喃-4-基，R8是氢原子或糖基，条件是当R7为2,5 - 二氢-2-氧代呋喃-4-基，则R8不是氢原子，或其对应的4,5-不饱和化合物作为活性成分，用于制备用于治疗病毒性疾病的药物。